Table 1.
Baseline distributions of potential mediators and confounders by race and ethnicity, N = 6078.
| Variables | Class | Total |
Race and Ethnicity |
P-value | |||||
|---|---|---|---|---|---|---|---|---|---|
| White | Black | Hispanic | AAPI | Other | |||||
| Mediators: Social and Economic Conditions |
Married | Yes | 3395 (55.7) | 2494 (60.8) | 147 (31.8) | 435 (55.3) | 175 (59.7) | 144 (41.6) | <0.0001 |
| Education | * | 10.83 (0.04) | 10.82 (0.05) | 10.31 (0.13) | 10.74 (0.13) | 12.11 (0.23) | 11.26 (0.21) | <0.0001 | |
| Household Income | * | 10.88 (0.08) | 11.38 (0.08) | 8.15 (0.26) | 10.76 (0.23) | 11.77 (0.33) | 10.68 (0.45) | <0.0001 | |
| Work Status | Yes | 3385 (56.8) | 2172 (55.0) | 263 (53.5) | 560 (62.6) | 224 (67.8) | 166 (56.7) | 0.0016 | |
| Mediators: Chronic Health Conditions |
Asthma | Yes | 702 (11.9) | 468 (11.6) | 66 (15.7) | 87 (9.3) | 32 (11.8) | 49 (16.8) | 0.0527 |
| Autoimmune Disease | Yes | 379 (5.5) | 295 (6.7) | 26 (4.8) | 34 (3.5) | 7 (1.4) | 17 (3.4) | 0.0027 | |
| Cancer | Yes | 428 (6.0) | 336 (6.9) | 29 (5.9) | 23 (3.3) | 14 (5.2) | 26 (4.3) | 0.0462 | |
| COPD | Yes | 237 (4.1) | 202 (5.3) | 12 (3.2) | 8 (1.2) | 2 (1.1) | 13 (3.2) | 0.0010 | |
| Diabetes | Yes | 738 (12.3) | 482 (11.5) | 84 (16.9) | 106 (13.5) | 21 (6.1) | 45 (14.7) | 0.0087 | |
| Heart Disesase | Yes | 392 (6.2) | 326 (8.0) | 18 (3.5) | 13 (2.1) | 9 (2.5) | 26 (7.7) | <0.0001 | |
| Hypertension | Yes | 1926 (31.0) | 1405 (32.7) | 200 (40.1) | 159 (22.7) | 60 (16.7) | 102 (30.1) | <0.0001 | |
| Kidney Disease | Yes | 163 (2.7) | 114 (2.6) | 24 (3.9) | 12 (2.4) | 3 (0.8) | 10 (4.9) | 0.2051 | |
| Mental Disorders | Yes | 661 (11.1) | 482 (12.9) | 40 (8.6) | 76 (7.3) | 23 (6.0) | 40 (13.7) | 0.0009 | |
| Obesity | Yes | 1070 (16.4) | 723 (16.4) | 92 (18.2) | 168 (17.0) | 22 (6.4) | 65 (23.7) | 0.0036 | |
| Disability | Yes | 509 (9.3) | 346 (9.6) | 75 (16.3) | 49 (5.5) | 4 (2.0) | 35 (9.5) | <0.0001 | |
| Sum of Chronic Conditions | * | 1.14 (0.02) | 1.22 (0.03) | 1.32 (0.08) | 0.85 (0.07) | 0.59 (0.08) | 1.28 (0.15) | <0.0001 | |
| Mediators: Psychological Factors |
Trust 1 | * | 2.48 (0.02) | 2.57 (0.02) | 2.02 (0.05) | 2.38 (0.05) | 2.68 (0.06) | 2.52 (0.09) | <0.0001 |
| Trust 2 | * | 2.30 (0.02) | 2.37 (0.02) | 1.90 (0.05) | 2.23 (0.05) | 2.56 (0.06) | 2.30 (0.09) | <0.0001 | |
| COVID Risk | * | 1.92 (0.04) | 1.79 (0.04) | 2.29 (0.12) | 2.20 (0.11) | 1.66 (0.15) | 1.94 (0.18) | <0.0001 | |
| Discrimination | Yes | 344 (6.0) | 190 (5.3) | 31 (7.4) | 76 (7.4) | 26 (7.1) | 21 (5.1) | 0.3334 | |
| Confounders | Age | * | 48.76 (0.29) | 50.86 (0.36) | 47.40 (0.83) | 43.84 (0.74) | 44.97 (1.44) | 45.31 (1.43) | <0.0001 |
| Gender | F | 3571 (51.7) | 2286 (47.9) | 333 (62.1) | 586 (58.6) | 193 (48.5) | 173 (54.5) | <0.0001 | |
| Total | 6068 (100) | 4064 (62.6) | 479 (12.0) | 897 (16.7) | 332 (5.4) | 296 (3.3) | |||
Note. Except the Hispanic group, all listed racial and ethnic groups are non-Hispanic. *: continuous variables. For continuous variables, each cell shows weighted mean and standard error; for categorical variables, each cell shows raw number and weighted percent. Total in the variable column refers to total sample distribution by race/ethnicity, with raw number and weighted percent for each race or ethnicity. Trust1 refers to trust in the vaccine development process and trust2 refers to trust in vaccine approval process. F refers to female.